Carter CL, Allen C., Henson DERelation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.
2.
Rivadeneira DE, Simmons RM, Christos PJ, Hanna K., Daly JM, Osborne MPPredictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg. 2000;191:1-8.
3.
Gann PH, Colilla SA, Gapstur SM, Winchester DJ, Winchester DPFactors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses. Cancer. 1999;86:1511-1519.
4.
Newman EA, Newman LALymphatic mapping techniques and sentinel lymph node biopsy in breast cancer . Surg Clin North Am. 2007;87:353-364.
5.
Nakajima M., Takeda M., Kobayashi M., Suzuki S., Ohuchi N.Nano-sized fluorescent particles as new tracers for sentinel node detection: experimental model for decision of appropriate size and wavelength. Cancer Sci. 2005;96:353-356.
6.
Gopee NV, Roberts DW, Webb P., et al. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci. 2007;98:249-257.
7.
Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NAVariables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett. 2007 ;7:1344-1348.